Éva Bozó

Title: Éva Bozó: Innovator in Pharmaceutical Chemistry

Introduction

Éva Bozó is a distinguished inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds that target specific receptor functions. His work has implications for the treatment of various medical conditions.

Latest Patents

Éva Bozó holds a patent for "Triazolobenzazepines as vasopressin V1a receptor antagonists." This invention relates to 5,6-dihydro-4H-[1,2,4]triazolo[4,3-a][1]benzazepine derivatives, which serve as V1a receptor modulators. The patent encompasses various forms of these compounds, including salts, isomers, and biologically active metabolites. The invention also details the preparation process for these compounds and their potential use in pharmaceutical compositions aimed at treating conditions associated with V1a receptor function.

Career Highlights

Éva Bozó is currently associated with Richter Gedeon Nyrt., a prominent pharmaceutical company in Hungary. His role involves research and development of innovative therapeutic solutions. His expertise in receptor antagonism has positioned him as a key figure in advancing pharmaceutical science.

Collaborations

Throughout his career, Éva Bozó has collaborated with notable colleagues, including Ferenc Baska and Imre Bata. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to the development of effective pharmaceutical products.

Conclusion

Éva Bozó's contributions to pharmaceutical chemistry, particularly through his patent on V1a receptor antagonists, highlight his role as an innovator in the field. His work continues to influence the development of new therapeutic strategies.